Cite
HARVARD Citation
Kraaij, T. et al. (n.d.). SAT0258 Synergetic b-cell immunomodulation with rituximab and belimumab is clinically effective in severe and refractory systemic lupus erythematosus – the synbiose proof-of-concept study. Annals of the rheumatic diseases. p. 871. [Online].